Brief: TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results
Nov 14 (Reuters) - Tracon Pharmaceuticals Inc TCON.O :
* TRACON PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* CASH AND CASH EQUIVALENTS WERE $17.0 MILLION AT SEPTEMBER
30,
2022, COMPARED TO $24.1 MILLION AT DECEMBER 31, 2021
* CASH AND CASH EQUIVALENTS EXPECTED TO FUND CO INTO
MID-2023
* QTRLY LOSS PER SHARE $0.30
* Q3 EARNINGS PER SHARE VIEW $-0.28 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbH5l8n
Further company coverage: TCON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants